Your browser doesn't support javascript.
loading
The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.
Qin, Wei; Zhang, Xiaqing; Wang, Yao; Pan, Fan; Cheng, Kai; Huang, Fangfang; Song, Jian; Su, Hong.
Afiliación
  • Qin W; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, China.
  • Zhang X; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, China.
  • Wang Y; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, China.
  • Pan F; Department of Health Inspection and Quarantine, School of Public Health, Anhui Medical University, Hefei, China.
  • Cheng K; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, China.
  • Huang F; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, China.
  • Song J; Department of Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, China.
  • Su H; Department of Preventive Medicine, School of Public Health, Bengbu Medical College, Bengbu, China.
Front Public Health ; 10: 943876, 2022.
Article en En | MEDLINE | ID: mdl-35979461

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / COVID-19 Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza